Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chimerism induction in the immune system is a therapeutic strategy aimed at establishing a state of coexistence between donor and recipient hematopoietic cells, primarily to induce immune tolerance and prevent graft rejection in transplantation. This involves creating mixed chimerism where both donor and recipient immune systems interact to promote long-term tolerance, often through mechanisms such as clonal deletion, anergy, and regulatory T cell activity. Various methods, including hematopoietic stem cell transplantation and combined organ/bone marrow transplantation, are used to achieve this goal. Clinical applications focus on reducing or eliminating the need for chronic immunosuppression in transplant recipients.
Induction of donor-recipient hematopoietic chimerism leading to central and peripheral immune tolerance to donor antigens.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Chimerism Induction).